Zaki Mohamed 4

4 · ADC Therapeutics SA · Filed Feb 18, 2026

AI-generated summary of this filing

Updated Feb 18, 2026

ADC Therapeutics (ADCT) CMO Zaki Mohamed Receives Award

What Happened

Zaki Mohamed, Chief Medical Officer of ADC Therapeutics (ADCT), was awarded 285,200 common shares (restricted share units) on 2026-02-13 at a reported value/price of $3.99/share (total value $1,137,948). On the same date the issuer withheld 24,603 shares at $3.99/share (value $98,166) to satisfy the reporting person’s tax withholding obligations related to previously vested RSUs. The 285,200-share award vests one-third on each anniversary starting Feb 13, 2027 (per filing footnote).

Key Details

Transaction dates and prices:
- 2026-02-13 — Award (code A): 285,200 shares @ $3.99 = $1,137,948 (RSU grant)
- 2026-02-13 — Tax withholding (code F): 24,603 shares @ $3.99 = $98,166 (shares withheld/ disposed to cover taxes)
Shares owned after transaction: Not specified in the Form 4 filing.
Footnotes:
- F1: Awarded RSUs settle as common shares and vest 1/3 on each anniversary beginning Feb 13, 2027, subject to continued service.
- F2: The withheld 24,603 shares were retained by the issuer to satisfy tax withholding on vested RSUs previously granted.
Filing timeliness: Form 4 filed 2026-02-18 for a 2026-02-13 transaction — appears filed within the required reporting window (timely).

Context

These transactions are RSU awards and corporate tax-withholding actions, not open-market purchases or sales. The award itself is compensation (not a buy signal); the withheld shares represent a tax settlement rather than a discretionary sale.

Form 4

Period: 2026-02-13

Chief Medical Officer

Transactions

Footnotes (2)

[F1]Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2026, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event.
[F2]Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.

Signature

/s/ Lisa Kallebo, Attorney-in-Fact for Mohamed Zaki|2026-02-18

1 file